Franklin Resources
KNSA icon

Franklin Resources’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Franklin Resources’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$818K Buy
12,788
+7,844
+159% +$407K ﹤0.01% 2368
2026
Q1 		$238K Buy
4,944
+1
+0% +$44 ﹤0.01% 2735
2025
Q4 		$204K Buy
+4,943
New +$198K ﹤0.01% 2789
2025
Q3 		– Sell
-108,574
Closed -$3M – 3201
2025
Q2 		$3M Buy
108,574
+41,632
+62% +$1.06M ﹤0.01% 1560
2025
Q1 		$1.49M Sell
66,942
-378
-0.6% -$7.78K ﹤0.01% 1807
2024
Q4 		$1.33M Sell
67,320
-213
-0.3% -$4.86K ﹤0.01% 1864
2024
Q3 		$1.8M Buy
67,533
+1,100
+2% +$26.8K ﹤0.01% 1777
2024
Q2 		$1.24M Buy
66,433
+2,402
+4% +$45K ﹤0.01% 1852
2024
Q1 		$1.26M Buy
64,031
+37,283
+139% +$728K ﹤0.01% 1870
2023
Q4 		$469K Buy
26,748
+96
+0.4% +$1.58K ﹤0.01% 1976
2023
Q3 		$463K Sell
26,652
-2,452
-8% -$41.3K ﹤0.01% 1955
2023
Q2 		$410K Buy
+29,104
New +$390K ﹤0.01% 2062

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Franklin Resources's KNSA Position: Q2 2026 in Review

Franklin Resources increased its Kiniksa Pharmaceuticals (KNSA) stake by 159% in Q2 2026, buying an estimated $407K and bringing the position to 12,788 shares worth $818K. The position accounts for ﹤0.01% of the portfolio, ranked #2368.

Franklin Resources first reported a position in KNSA in Q2 2023 and has held it in 12 quarters since. The position peaked at $3M in Q2 2025. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Franklin Resources held 12,788 shares of Kiniksa Pharmaceuticals worth $818K as of Q2 2026.
  • Franklin Resources bought 7,844 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $407K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2368 holding.
  • Franklin Resources first reported a position in Kiniksa Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
  • Franklin Resources's Kiniksa Pharmaceuticals position peaked at $3M in Q2 2025.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.